 Eileen Chang
Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetal Growth Retardation | 8 | 2025 | 591 | 2.410 |
Why?
| | Placental Insufficiency | 6 | 2025 | 126 | 2.320 |
Why?
| | Sheep | 24 | 2026 | 880 | 1.690 |
Why?
| | Fetus | 15 | 2024 | 800 | 1.650 |
Why?
| | Ketamine | 5 | 2018 | 133 | 1.380 |
Why?
| | Fetal Hypoxia | 6 | 2018 | 56 | 1.290 |
Why?
| | Muscle, Skeletal | 8 | 2026 | 1784 | 1.030 |
Why?
| | Muscle, Striated | 1 | 2026 | 12 | 0.940 |
Why?
| | Ploidies | 1 | 2025 | 19 | 0.940 |
Why?
| | Microvessels | 1 | 2026 | 98 | 0.860 |
Why?
| | Fetal Development | 3 | 2024 | 295 | 0.860 |
Why?
| | Fetal Heart | 1 | 2024 | 56 | 0.800 |
Why?
| | Mitochondria, Heart | 1 | 2024 | 101 | 0.790 |
Why?
| | Myocytes, Cardiac | 2 | 2025 | 538 | 0.780 |
Why?
| | Cell Cycle | 2 | 2025 | 595 | 0.770 |
Why?
| | Muscle Development | 2 | 2021 | 113 | 0.750 |
Why?
| | Insulin-Like Growth Factor I | 5 | 2024 | 317 | 0.710 |
Why?
| | Myoblasts, Skeletal | 1 | 2021 | 12 | 0.710 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2021 | 214 | 0.670 |
Why?
| | Pregnancy | 18 | 2025 | 7112 | 0.650 |
Why?
| | Amino Acids | 3 | 2022 | 518 | 0.630 |
Why?
| | Insulin | 4 | 2024 | 2500 | 0.550 |
Why?
| | Excitatory Amino Acid Antagonists | 2 | 2018 | 107 | 0.490 |
Why?
| | Hypoxia, Brain | 1 | 2016 | 9 | 0.480 |
Why?
| | Cerebral Cortex | 2 | 2018 | 470 | 0.470 |
Why?
| | Animals | 31 | 2026 | 37800 | 0.460 |
Why?
| | Adrenocorticotropic Hormone | 2 | 2016 | 147 | 0.450 |
Why?
| | Lower Extremity | 1 | 2019 | 440 | 0.450 |
Why?
| | Anesthetics, Dissociative | 1 | 2015 | 46 | 0.430 |
Why?
| | Neuroprotective Agents | 1 | 2016 | 143 | 0.430 |
Why?
| | Hydrocortisone | 2 | 2016 | 297 | 0.400 |
Why?
| | Citrate (si)-Synthase | 2 | 2024 | 53 | 0.380 |
Why?
| | Inflammation Mediators | 1 | 2016 | 503 | 0.380 |
Why?
| | Hypoxia | 5 | 2020 | 1193 | 0.370 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 475 | 0.360 |
Why?
| | Hypoglycemic Agents | 1 | 2021 | 1388 | 0.360 |
Why?
| | Hypothalamus | 3 | 2016 | 160 | 0.300 |
Why?
| | Female | 26 | 2026 | 78137 | 0.300 |
Why?
| | Gestational Age | 5 | 2025 | 980 | 0.280 |
Why?
| | Pregnancy, Animal | 2 | 2019 | 51 | 0.270 |
Why?
| | Kidney | 1 | 2015 | 1493 | 0.260 |
Why?
| | Umbilical Cord | 2 | 2018 | 92 | 0.250 |
Why?
| | Disease Models, Animal | 7 | 2025 | 4525 | 0.230 |
Why?
| | Oxidative Phosphorylation | 2 | 2024 | 209 | 0.230 |
Why?
| | Muscle Fibers, Slow-Twitch | 1 | 2025 | 23 | 0.230 |
Why?
| | Matrix Metalloproteinases | 3 | 2010 | 95 | 0.230 |
Why?
| | Capillaries | 1 | 2025 | 118 | 0.210 |
Why?
| | Neovascularization, Physiologic | 1 | 2026 | 191 | 0.210 |
Why?
| | Infusions, Intravenous | 2 | 2024 | 422 | 0.210 |
Why?
| | Cell Respiration | 1 | 2024 | 105 | 0.210 |
Why?
| | DNA Replication | 1 | 2025 | 252 | 0.200 |
Why?
| | Islets of Langerhans | 2 | 2021 | 839 | 0.200 |
Why?
| | Animals, Newborn | 1 | 2026 | 888 | 0.200 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2026 | 549 | 0.190 |
Why?
| | Ventricular Remodeling | 3 | 2010 | 275 | 0.190 |
Why?
| | Drug Administration Schedule | 2 | 2021 | 779 | 0.190 |
Why?
| | Fetal Blood | 3 | 2021 | 325 | 0.180 |
Why?
| | Muscle Proteins | 2 | 2022 | 240 | 0.170 |
Why?
| | Transcriptome | 3 | 2018 | 1034 | 0.170 |
Why?
| | Placenta | 4 | 2021 | 781 | 0.160 |
Why?
| | Lipid Metabolism | 1 | 2024 | 522 | 0.160 |
Why?
| | Bromodeoxyuridine | 1 | 2019 | 77 | 0.150 |
Why?
| | Glucose | 2 | 2024 | 1033 | 0.150 |
Why?
| | Hindlimb | 1 | 2019 | 131 | 0.140 |
Why?
| | Sheep, Domestic | 2 | 2016 | 34 | 0.140 |
Why?
| | Alanine | 1 | 2019 | 170 | 0.140 |
Why?
| | Coronary Vessels | 1 | 2020 | 246 | 0.140 |
Why?
| | Cell Proliferation | 1 | 2025 | 2485 | 0.140 |
Why?
| | Cell Differentiation | 1 | 2025 | 2033 | 0.130 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2016 | 749 | 0.130 |
Why?
| | Staphylococcus | 1 | 2017 | 75 | 0.130 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2017 | 81 | 0.130 |
Why?
| | Ventricular Function, Left | 2 | 2010 | 535 | 0.120 |
Why?
| | Temperature | 1 | 2019 | 675 | 0.120 |
Why?
| | Selection, Genetic | 2 | 2012 | 256 | 0.120 |
Why?
| | Triclosan | 1 | 2016 | 9 | 0.120 |
Why?
| | Anti-Infective Agents, Local | 1 | 2016 | 40 | 0.120 |
Why?
| | Gene Expression Profiling | 4 | 2016 | 1762 | 0.120 |
Why?
| | Endocrine Disruptors | 1 | 2016 | 40 | 0.120 |
Why?
| | Systems Biology | 1 | 2016 | 72 | 0.110 |
Why?
| | Pituitary Gland | 1 | 2016 | 148 | 0.110 |
Why?
| | Ischemia | 1 | 2018 | 421 | 0.110 |
Why?
| | Mitochondria | 1 | 2021 | 981 | 0.110 |
Why?
| | Oxidative Stress | 1 | 2021 | 1331 | 0.110 |
Why?
| | Chemokines | 1 | 2015 | 217 | 0.110 |
Why?
| | Brachiocephalic Trunk | 1 | 2014 | 11 | 0.110 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 228 | 0.110 |
Why?
| | Analgesics | 1 | 2016 | 232 | 0.100 |
Why?
| | Interleukins | 1 | 2015 | 248 | 0.100 |
Why?
| | Saccharomyces cerevisiae | 2 | 2012 | 577 | 0.100 |
Why?
| | Blood Pressure | 3 | 2016 | 1763 | 0.100 |
Why?
| | RNA, Messenger | 3 | 2016 | 2808 | 0.100 |
Why?
| | Endocrine System | 1 | 2013 | 22 | 0.100 |
Why?
| | Myosin Light Chains | 1 | 2012 | 26 | 0.090 |
Why?
| | Cardiac Myosins | 1 | 2012 | 37 | 0.090 |
Why?
| | Two-Hybrid System Techniques | 1 | 2012 | 59 | 0.090 |
Why?
| | Molecular Biology | 1 | 2012 | 56 | 0.090 |
Why?
| | Immune System | 1 | 2013 | 178 | 0.090 |
Why?
| | Transcription Factors | 2 | 2014 | 1726 | 0.090 |
Why?
| | Cardiomegaly | 1 | 2012 | 174 | 0.080 |
Why?
| | Apoptosis | 1 | 2019 | 2395 | 0.080 |
Why?
| | Myocardial Contraction | 1 | 2012 | 287 | 0.080 |
Why?
| | Hemodynamics | 1 | 2016 | 1113 | 0.080 |
Why?
| | Gene Expression | 1 | 2016 | 1474 | 0.080 |
Why?
| | Estradiol | 1 | 2014 | 507 | 0.080 |
Why?
| | Homeodomain Proteins | 1 | 2014 | 523 | 0.080 |
Why?
| | Electric Stimulation Therapy | 1 | 2010 | 62 | 0.080 |
Why?
| | Heart Conduction System | 1 | 2010 | 95 | 0.080 |
Why?
| | Stress, Physiological | 1 | 2012 | 446 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2016 | 2589 | 0.070 |
Why?
| | Up-Regulation | 4 | 2014 | 847 | 0.070 |
Why?
| | Basigin | 1 | 2008 | 24 | 0.070 |
Why?
| | Adaptation, Physiological | 1 | 2012 | 566 | 0.070 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2010 | 138 | 0.070 |
Why?
| | Genomics | 1 | 2013 | 828 | 0.070 |
Why?
| | Fibroblasts | 2 | 2010 | 1017 | 0.070 |
Why?
| | Brain | 2 | 2017 | 2929 | 0.060 |
Why?
| | Aorta, Thoracic | 1 | 2010 | 283 | 0.060 |
Why?
| | Arrhythmias, Cardiac | 1 | 2010 | 355 | 0.060 |
Why?
| | Time Factors | 2 | 2016 | 7128 | 0.060 |
Why?
| | Heart Defects, Congenital | 1 | 2014 | 896 | 0.060 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2008 | 392 | 0.050 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2010 | 643 | 0.050 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2012 | 417 | 0.050 |
Why?
| | Oxygen | 2 | 2021 | 978 | 0.050 |
Why?
| | Inflammation | 1 | 2015 | 2862 | 0.050 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2016 | 339 | 0.050 |
Why?
| | Genetic Complementation Test | 1 | 2003 | 66 | 0.050 |
Why?
| | Myocardium | 1 | 2008 | 927 | 0.050 |
Why?
| | Adenocarcinoma | 1 | 2010 | 919 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2018 | 905 | 0.050 |
Why?
| | Energy Metabolism | 2 | 2021 | 925 | 0.050 |
Why?
| | Mice, Transgenic | 3 | 2014 | 2177 | 0.050 |
Why?
| | Myocardial Infarction | 1 | 2010 | 1209 | 0.050 |
Why?
| | Leucine | 1 | 2022 | 116 | 0.050 |
Why?
| | Ventricular Pressure | 2 | 2012 | 52 | 0.040 |
Why?
| | Infusion Pumps | 1 | 2021 | 33 | 0.040 |
Why?
| | Down-Regulation | 2 | 2014 | 613 | 0.040 |
Why?
| | Blood Glucose | 2 | 2024 | 2326 | 0.040 |
Why?
| | Placental Circulation | 1 | 2021 | 71 | 0.040 |
Why?
| | Fetal Macrosomia | 1 | 2021 | 62 | 0.040 |
Why?
| | Placentation | 1 | 2021 | 52 | 0.040 |
Why?
| | Fetal Weight | 1 | 2021 | 53 | 0.040 |
Why?
| | Pancreatic Diseases | 1 | 2021 | 66 | 0.040 |
Why?
| | Male | 9 | 2021 | 72263 | 0.040 |
Why?
| | Organ Size | 1 | 2021 | 461 | 0.040 |
Why?
| | Matrix Metalloproteinase 2 | 2 | 2010 | 55 | 0.040 |
Why?
| | Fetal Diseases | 1 | 2021 | 193 | 0.040 |
Why?
| | Heart Failure | 1 | 2012 | 2323 | 0.040 |
Why?
| | Insulin-Like Growth Factor II | 1 | 2018 | 24 | 0.040 |
Why?
| | Swine | 2 | 2010 | 817 | 0.030 |
Why?
| | Aging | 1 | 2008 | 1935 | 0.030 |
Why?
| | Heart Ventricles | 2 | 2014 | 750 | 0.030 |
Why?
| | Mice, Inbred C57BL | 3 | 2014 | 5954 | 0.030 |
Why?
| | Diabetes, Gestational | 1 | 2021 | 303 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 2018 | 342 | 0.030 |
Why?
| | Arteries | 1 | 2018 | 257 | 0.030 |
Why?
| | Lung Neoplasms | 1 | 2010 | 2643 | 0.030 |
Why?
| | Echocardiography | 2 | 2010 | 644 | 0.030 |
Why?
| | Heart Rate | 2 | 2010 | 849 | 0.030 |
Why?
| | Stroke Volume | 2 | 2010 | 650 | 0.030 |
Why?
| | Maternal-Fetal Exchange | 1 | 2016 | 169 | 0.030 |
Why?
| | Microglia | 1 | 2017 | 269 | 0.030 |
Why?
| | Homeobox Protein Nkx-2.5 | 1 | 2014 | 6 | 0.030 |
Why?
| | Carbon Dioxide | 1 | 2016 | 237 | 0.030 |
Why?
| | Reproduction | 1 | 2016 | 205 | 0.030 |
Why?
| | Gene Knock-In Techniques | 1 | 2014 | 60 | 0.030 |
Why?
| | Neuropeptides | 1 | 2014 | 74 | 0.030 |
Why?
| | Mice | 4 | 2014 | 18218 | 0.030 |
Why?
| | Phenotype | 2 | 2014 | 3139 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2013 | 3408 | 0.020 |
Why?
| | Disease Progression | 2 | 2012 | 2844 | 0.020 |
Why?
| | Heterozygote | 1 | 2014 | 313 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2016 | 318 | 0.020 |
Why?
| | Models, Genetic | 1 | 2016 | 531 | 0.020 |
Why?
| | Gene Ontology | 1 | 2013 | 54 | 0.020 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2012 | 19 | 0.020 |
Why?
| | Pulmonary Ventilation | 1 | 2013 | 82 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 84 | 0.020 |
Why?
| | Ubiquitin | 1 | 2012 | 83 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2014 | 338 | 0.020 |
Why?
| | Lymphocytes | 1 | 2014 | 379 | 0.020 |
Why?
| | Culture Media | 1 | 2012 | 161 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2014 | 847 | 0.020 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2012 | 153 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2014 | 400 | 0.020 |
Why?
| | Brain Ischemia | 1 | 2014 | 358 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2014 | 2127 | 0.020 |
Why?
| | Calcium Chloride | 1 | 2010 | 11 | 0.020 |
Why?
| | Feeding Behavior | 1 | 2016 | 686 | 0.020 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2010 | 150 | 0.020 |
Why?
| | Diastole | 1 | 2010 | 142 | 0.020 |
Why?
| | Thoracotomy | 1 | 2010 | 80 | 0.020 |
Why?
| | Systole | 1 | 2010 | 177 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2014 | 2896 | 0.020 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2010 | 84 | 0.020 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2010 | 130 | 0.020 |
Why?
| | Angiotensin II | 1 | 2010 | 95 | 0.020 |
Why?
| | Aorta | 1 | 2012 | 426 | 0.020 |
Why?
| | Macrophages | 1 | 2017 | 1496 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2014 | 668 | 0.020 |
Why?
| | Pacemaker, Artificial | 1 | 2010 | 126 | 0.020 |
Why?
| | Matrix Metalloproteinase 14 | 1 | 2008 | 3 | 0.020 |
Why?
| | Extracellular Matrix Proteins | 1 | 2010 | 155 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2010 | 762 | 0.020 |
Why?
| | Endothelin-1 | 1 | 2010 | 181 | 0.020 |
Why?
| | Tachycardia, Ventricular | 1 | 2010 | 180 | 0.020 |
Why?
| | Phosphorylation | 1 | 2012 | 1702 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 971 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2010 | 475 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2014 | 3106 | 0.020 |
Why?
| | Electrocardiography | 1 | 2010 | 663 | 0.020 |
Why?
| | Fibrosis | 1 | 2008 | 547 | 0.010 |
Why?
| | Collagen | 1 | 2008 | 450 | 0.010 |
Why?
| | Recovery of Function | 1 | 2010 | 715 | 0.010 |
Why?
| | Genotype | 1 | 2010 | 1843 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1699 | 0.010 |
Why?
| | Humans | 5 | 2021 | 144298 | 0.010 |
Why?
| | Retinoid X Receptors | 1 | 2003 | 38 | 0.010 |
Why?
| | Receptors, Retinoic Acid | 1 | 2003 | 42 | 0.010 |
Why?
| | Tocopherols | 1 | 2003 | 31 | 0.010 |
Why?
| | Receptors, Steroid | 1 | 2003 | 41 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2003 | 372 | 0.010 |
Why?
| | Tretinoin | 1 | 2003 | 124 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2010 | 4102 | 0.010 |
Why?
| | Paclitaxel | 1 | 2003 | 254 | 0.010 |
Why?
| | Molecular Structure | 1 | 2003 | 490 | 0.010 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 204 | 0.010 |
Why?
| | Ligands | 1 | 2003 | 661 | 0.010 |
Why?
| | Age Factors | 1 | 2008 | 3324 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2003 | 666 | 0.010 |
Why?
| | Antioxidants | 1 | 2003 | 542 | 0.010 |
Why?
| | Protein Binding | 1 | 2003 | 2241 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1483 | 0.010 |
Why?
| | Signal Transduction | 1 | 2008 | 5182 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2003 | 2194 | 0.010 |
Why?
|
|
Chang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|